Calcitonin-negative medullary thyroid carcinoma combined with multifocal papillary thyroid carcinoma: a case report and literature review
Open Access
- 23 January 2026
- journal article
- case report
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Abstract
Calcitonin-negative medullary thyroid cancer (CTNMTC) is a rare primary thyroid neuroendocrine carcinoma characterised by medullary thyroid carcinoma (MTC)Keywords
Funding Information
- Jinan Science and Technology Bureau (202134064)
- Taishan Scholars Program of Shandong Province (tsqnz202408368)
- National Natural Science Foundation of China (82002832)
- Natural Science Foundation of Shandong Province (ZR2024MH190)
- International diabetes Exchange and Practice Special fund of China, the International Medical Exchange Foundation (Z-2017-26-2202-4)
This publication has 34 references indexed in Scilit:
- False Positives in Thyroglobulin Determinations Due to the Presence of Heterophile Antibodies: An Underrecognized and Consequential Clinical ProblemEndocrine Practice, 2021
- Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer CenterHead and Neck Pathology, 2021
- Serum calcitonin negative mixed medullary‐follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine‐needle aspiration cytology: A case report and review of the literaturesDiagnostic Cytopathology, 2018
- Clinical challenges with calcitonin-negative medullary thyroid carcinomaJournal of Cancer Research and Clinical Oncology, 2016
- Heterophilic antibody interference in immunometric assaysBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- True Mixed Medullary Papillary Carcinoma of the Thyroid: a Case Report with Low Blood Calcitonin LevelsEndocrine Pathology, 2012
- Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literatureUpdates in Surgery, 2012
- Mixed Medullary-Follicular Thyroid CarcinomaThe American Journal of Pathology, 1999
- Hormone-Negative, Chromogranin a-Positive Endocrine TumorsNew England Journal of Medicine, 1989
- A compound follicular-parafollicular cell carcinoma of the thyroid: A new tumor entity?Cancer, 1983